HOME >> MEDICINE >> NEWS
Researchers identify new therapy for patients with Crohn's disease

ROCHESTER, Minn. -- A study led by Mayo Clinic found that adalimumab (HUMIRA)) is an effective treatment for adults with Crohns disease who do not respond to infliximab (REMICADE) therapy. These findings were published online today by Annals of Internal Medicine.

Crohns disease is an inflammatory disorder of the gastrointestinal tract that affects an estimated 500,000 people in the United States. Symptoms include abdominal pain, fever, nausea, vomiting, weight loss and diarrhea. Crohns disease has no known medical cure. One common therapy is a series of intravenous infusions of infliximab, which blocks tumor necrosis factor, an important cause of inflammation in Crohns disease.

"Approximately 50 percent of Crohns disease patients who receive repeated administration of infliximab will eventually develop an allergic reaction, need higher doses, or completely stop responding to the therapy," says William J. Sandborn, M.D., the lead author and a gastroenterologist at Mayo Clinic. "Our goal with this study was to determine if adalimumab was a safe and effective alternative for these patients."

Like infliximab, adalimumab is a human monoclonal antibody that blocks tumor necrosis factor. However, it is administered via a series of subcutaneous injections, rather than intravenously.

The study included 325 patients at 52 sites with moderate to severe Crohns disease who continued to have symptoms despite infliximab therapy or who could not take infliximab due to an allergic reaction. Researchers found that 21 percent of patients who received adalimumab achieved remission after four weeks, while just 7 percent of patients who received a placebo achieved remission in the same period. Fifty-two percent of patients who received adalimumab achieved an improvement in their clinical symptoms as compared with 34 percent of patients who received a placebo.

"This study demonstrates that in the short term, adalimumab can be safely
'"/>

Contact: Elizabeth Rice
newsbureau@mayo.edu
507-284-5005
Mayo Clinic
1-May-2007


Page: 1 2

Related medicine news :

1. Researchers suggest TB screening for all international adoptees
2. Researchers find vitamin B1 deficiency key to vascular problems for diabetic patients
3. Researchers link metal ions to neurodegenerative disease
4. Researchers develop criteria to detect bone mass deficiencies in children with chronic diseases
5. Researchers call for investigation into links between khat use and psychiatric disorders
6. Researchers use MRI to predict recovery after spinal cord injury
7. Researchers find deadly prescription drug effects 6 years before FDA
8. Researchers investigate impact of lifestyle on GI health
9. Researchers begin randomized double-blind trial of airway bypass treatment for emphysema
10. Researchers discover how antibiotic inhibits bacterial growth
11. Researchers urge caution in using ESAs for cancer-related anemia

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/9/2018)... ... 2018 , ... RiverGlade Capital (“RiverGlade”), is pleased to announce ... an exclusive relationship with the firm. As an Operating Partner, Mr. Hudak ... and deal origination, evaluation and diligence. He brings a wealth of healthcare ...
(Date:8/7/2018)... ... August 07, 2018 , ... Today ... Nancy’s Probiotic Foods. These rich, cream-on-top-style yogurts are made with milk from grass-fed ... that's high in omega-3 fatty acids. Nancy’s sources the milk from organic family-owned ...
(Date:8/3/2018)... ... August 03, 2018 , ... Yisrayl Hawkins, Pastor and Overseer ... secret passages and meanings from the Bible meant only to be understood in this ... he has been able to decode passages that he says scholars have struggled with ...
(Date:8/2/2018)... ... August 02, 2018 , ... Mindray, a ... Ultrasound system with unique new upgrades at the Society of Vascular Ultrasound annual ... Sonography® Technology (ZST), the upgrades include a unique arterial stiffness measurement, which uses ...
(Date:8/2/2018)... , ... August 02, 2018 ... ... medical claims management solutions provider, announced today that it has acquired Minneapolis, ... (IMEs), medical record reviews, peer reviews, and related services. , Medlogix seeks ...
Breaking Medicine News(10 mins):
(Date:8/7/2018)... ... August 07, 2018 , ... Commissioner Gottlieb’s FDA:, Analysis of First Year and ... p.m. ET, http://www.fdanews.com/commissionergottliebsfda , Under Commissioner Scott Gottlieb, changes at the ... some may have gotten hurt. , And Gottlieb is just getting started. , Mark ...
(Date:8/7/2018)... , ... August 07, 2018 , ... ... Joe Morehouse, DO, to its growing team of eye care providers. Dr. Morehouse ... and traditional intraocular lenses, as well as treating patients for routine eye care, ...
(Date:8/2/2018)... ... August 02, 2018 , ... The American Heart Association/American ... on Wednesday, July 11, 2018, recognizing the hospital’s commitment to compliance with quality ... , Get With The Guidelines®-Stroke Gold Plus Quality Achievement ...
Breaking Medicine Technology:
Cached News: